Skip Navigation

This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (26)
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Orr, H. T.
Right arrow Articles by Zoghbi, H. Y.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Orr, H. T.
Right arrow Articles by Zoghbi, H. Y.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Human Molecular Genetics, 2001, Vol. 10, No. 20 2307-2311
© 2001 Oxford University Press

SCA1 molecular genetics: a history of a 13 year collaboration against glutamines

Harry T. Orr+ and Huda Y. Zoghbi1

Institute of Human Genetics, Department of Laboratory Medicine and Pathology, Department of Genetics, Cell Biology and Development, University of Minnesota, Mayo Mail Code 206, Minneapolis, MN 55455, USA and 1Howard Hughes Medical Institute, Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, TX 77030, USA

Spinocerebellar ataxia type 1 (SCA1) is a relatively rare autosomal-dominant neurological disorder. SCA1 has the intriguing feature that the disease-causing mutation is the expansion of an unstable trinucleotide repeat, specifically a CAG repeat that encodes the amino acid glutamine in ataxin-1. During the past 10 years, substantial progress has been made towards understanding the pathogenic mechanism in this disease. The nucleus has been identified as the subcellular site where the mutant protein acts to cause disease. Evidence indicates that expansion of the glutamine tract alters the folding properties of ataxin-1. Finally, several cellular pathways have been identified which are able to impinge on the SCA1 disease process. The characterization of these pathways and their role in SCA1 will guide research over the next several years.

+ To whom correspondence should be addressed. Tel: +1 612 625 3647; Fax: +1 612 626 2600; Email: harry@lenti.med.umn.edu


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 J. Biol. Chem.Home page
T. A. Bolger, X. Zhao, T. J. Cohen, C.-C. Tsai, and T.-P. Yao
The Neurodegenerative Disease Protein Ataxin-1 Antagonizes the Neuronal Survival Function of Myocyte Enhancer Factor-2
J. Biol. Chem., October 5, 2007; 282(40): 29186 - 29192.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
A. Iwata, J. C. Christianson, M. Bucci, L. M. Ellerby, N. Nukina, L. S. Forno, and R. R. Kopito
Increased susceptibility of cytoplasmic over nuclear polyglutamine aggregates to autophagic degradation
PNAS, September 13, 2005; 102(37): 13135 - 13140.
[Abstract] [Full Text] [PDF]

Home page
 J. Cell Sci.Home page
S. Irwin, M. Vandelft, D. Pinchev, J. L. Howell, J. Graczyk, H. T. Orr, and R. Truant
RNA association and nucleocytoplasmic shuttling by ataxin-1
J. Cell Sci., January 1, 2005; 118(1): 233 - 242.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
Y. W. Chen, M. D. Allen, D. B. Veprintsev, J. Lowe, and M. Bycroft
The Structure of the AXH Domain of Spinocerebellar Ataxin-1
J. Biol. Chem., January 30, 2004; 279(5): 3758 - 3765.
[Abstract] [Full Text] [PDF]

Home page
 Hum Mol GenetHome page
D. P. Huynh, H.-T. Yang, H. Vakharia, D. Nguyen, and S. M. Pulst
Expansion of the polyQ repeat in ataxin-2 alters its Golgi localization, disrupts the Golgi complex and causes cell death
Hum. Mol. Genet., July 1, 2003; 12(13): 1485 - 1496.
[Abstract] [Full Text] [PDF]


Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.